PMDA: Notice Instructing Revision of Precautions for Pharmaceuticals (MHLW, Aug 17, 2026)
使用上の注意の改訂指示通知（医薬品）2026年08月17日付（厚生労働省より発出）を掲載しました
Published: 2026-08-17 · Source: Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Stage: Government Announcement · Area: Healthcare / Pharmaceuticals · Impact (preliminary): Medium · First detected by this dashboard: 2026-08-18
View the original Japanese source More Healthcare / Pharmaceuticals updates Search all updates in the dashboard
AI summary
Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.
Summary
The PMDA safety information page reports that it has posted a notice instructing revisions to the 'Precautions' (package insert warnings) for pharmaceuticals, dated August 17, 2026 and issued by the Ministry of Health, Labour and Welfare. This is a government announcement of a posted notice; the specific drugs and the content of the revisions are not given in the provided metadata.
Business Impact
Marketing authorization holders and healthcare providers handling the affected pharmaceuticals may need to update package inserts and related safety information, depending on which products the notice covers. Impact on any particular product cannot be determined from the available information.
Recommended Action
Review the official PMDA page and the underlying MHLW notice in Japanese to identify the affected drugs and the specific revisions.